Mathieu Kerneis

Interventional cardiologist at Pitié Salpêtrière Hospital (Sorbonne University) and Investigator of the ACTION Study Group.

Dr. Kerneis was member of the PERFUSE Study Group, at the Beth Israel Medical Center, Harvard Medical School in Boston. His research themes cover coronary diseases, thrombosis and acute myocarditis. Dr. Kerneis was the principal investigator of the recently completed ARAMIS Study (Anakinra Versus Placebo for the Treatment of Acute Myocarditis).


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Cardiol Therapeutics

Cardiol Therapeutics Inc. is a clinical-stage biotechnology company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease.


Industries

Headquarters

Oakville, Canada

Employees

11-50

Links